retatrutide updates FDA Approval Status 2026: Everything We Know So Far Retatrutide FDA Approval Status 2026:

As the semaglutide patent expiries begin in 2026 across key global markets, Indian pharma companies are racing to capture the opportunity amid rising competition, falling prices & regulatory uncertainty Ekta Bhatra breaks down who stands to gain, the risks ahead, & how GLP-1 drugs could drive the next phase of pharma growth

Learn why these GLP-1s underperform and how SLM+ helps you break through plateaus and keep losing weight.

Have I given up the fight for an easy option

This article is informational and not medical advice

Natural Metabolic Support Formulated with plant-based ingredients such as Berberine, Cinnamon, Turmeric, and Garcinia Cambogia to help support a balanced metabolism and natural energy function for everyday wellness

A runny nose during GLP-1 therapy raises questions about whether the medication itself causes nasal symptoms or if other factors are at play